- Home
- KORE vs SNTI Comparison
KORE vs SNTI Comparison
Compare KORE & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KORE
- SNTI
- Stock Information
- Founded
- KORE 2003
- SNTI 2016
- Country
- KORE United States
- SNTI United States
- Employees
- KORE N/A
- SNTI N/A
- Industry
- KORE Telecommunications Equipment
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- KORE Consumer Discretionary
- SNTI Health Care
- Exchange
- KORE Nasdaq
- SNTI Nasdaq
- Market Cap
- KORE 39.3M
- SNTI 39.6M
- IPO Year
- KORE N/A
- SNTI N/A
- Fundamental
- Price
- KORE $2.31
- SNTI $1.41
- Analyst Decision
- KORE Hold
- SNTI Strong Buy
- Analyst Count
- KORE 2
- SNTI 2
- Target Price
- KORE $2.75
- SNTI $8.50
- AVG Volume (30 Days)
- KORE 11.2K
- SNTI 115.8K
- Earning Date
- KORE 08-14-2025
- SNTI 08-07-2025
- Dividend Yield
- KORE N/A
- SNTI N/A
- EPS Growth
- KORE N/A
- SNTI N/A
- EPS
- KORE N/A
- SNTI N/A
- Revenue
- KORE $285,636,000.00
- SNTI N/A
- Revenue This Year
- KORE $4.46
- SNTI N/A
- Revenue Next Year
- KORE $5.94
- SNTI $150.00
- P/E Ratio
- KORE N/A
- SNTI N/A
- Revenue Growth
- KORE 0.24
- SNTI N/A
- 52 Week Low
- KORE $1.10
- SNTI $1.38
- 52 Week High
- KORE $4.88
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- KORE 54.17
- SNTI 29.30
- Support Level
- KORE $2.32
- SNTI $1.38
- Resistance Level
- KORE $2.59
- SNTI $1.65
- Average True Range (ATR)
- KORE 0.16
- SNTI 0.09
- MACD
- KORE 0.03
- SNTI 0.01
- Stochastic Oscillator
- KORE 71.43
- SNTI 12.18
About KORE KORE Group Holdings Inc.
Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.